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Abstract
Purebred dog health is thought to be compromised by an increasing occurence of inherited diseases but inadequate
prevalence data on common disorders have hampered efforts to prioritise health reforms. Analysis of primary veterinary
practice clinical data has been proposed for reliable estimation of disorder prevalence in dogs. Electronic patient record
(EPR) data were collected on 148,741 dogs attending 93 clinics across central and south-eastern England. Analysis in detail
of a random sample of EPRs relating to 3,884 dogs from 89 clinics identified the most frequently recorded disorders as otitis
externa (prevalence 10.2%, 95% CI: 9.1–11.3), periodontal disease (9.3%, 95% CI: 8.3–10.3) and anal sac impaction (7.1%, 95%
CI: 6.1–8.1). Using syndromic classification, the most prevalent body location affected was the head-and-neck (32.8%, 95%
CI: 30.7–34.9), the most prevalent organ system affected was the integument (36.3%, 95% CI: 33.9–38.6) and the most
prevalent pathophysiologic process diagnosed was inflammation (32.1%, 95% CI: 29.8–34.3). Among the twenty most-
frequently recorded disorders, purebred dogs had a significantly higher prevalence compared with crossbreds for three:
otitis externa (P = 0.001), obesity (P = 0.006) and skin mass lesion (P = 0.033), and popular breeds differed significantly from
each other in their prevalence for five: periodontal disease (P = 0.002), overgrown nails (P = 0.004), degenerative joint disease
(P = 0.005), obesity (P = 0.001) and lipoma (P = 0.003). These results fill a crucial data gap in disorder prevalence information
and assist with disorder prioritisation. The results suggest that, for maximal impact, breeding reforms should target
commonly-diagnosed complex disorders that are amenable to genetic improvement and should place special focus on at-
risk breeds. Future studies evaluating disorder severity and duration will augment the usefulness of the disorder prevalence
information reported herein.
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Introduction
The domestic dog (Canis lupus familiaris) has become integral to
modern human family life, with the UK dog population estimated
to be 8–10 million [1,2,3] and 24–31% of UK households
estimated to own at least one dog [1,2]. Although humans benefit
from dog ownership both physically [4,5] and mentally [6,7], it is
increasingly questioned whether modern breeding practices have
allowed dog health and welfare to derive comparable benefits
[8,9]. Although the dog is now the most phenotypically diverse
mammal at a species level [10], genetic diversity has been greatly
reduced within modern breeds [11] because of breeding practices
that include closed stud books [12], structured inbreeding [11] and
reproductive dominance of popular sires [13]. Additionally,
selection pressure within breeds towards phenotypic exaggeration
driven by breed standards [8], have increased the potential for
conformation-associated disease [14]. Each of the 50 most popular
breeds in the UK has at least one reported conformational
predisposition to disease [15] and almost 400 non-conformational
inherited disorders have been identified [16]. Conversely, implicit
acceptance of the statement that purebred dogs are plagued with
many inherited diseases [17] has contributed to a widespread
belief that crossbred dogs are substantially healthier than
purebreds [18].
Following claims in the BBC documentary Pedigree Dogs Exposed
that purebred dog health was deteriorating because of inbreeding
and ill-advised breed standards [19], three major reports
concurred that pedigree breeding practices did impose welfare
costs on dogs but, more crucially, concluded that a critical data
gap on disorder prevalence information in UK dogs constrained
effective reforms [20,21,22]. Prevalence data have been published
on only 1% of inherited disorders affecting popular UK dog
breeds [23]. Effective welfare reform of pedigree dog-breeding
must be underpinned by scientifically valid prioritisation of
disorders based on reliable and comparable prevalence data
[12,24]. However, differing case definitions, study populations,
geographical locations, data quality and data collection periods
between published studies, combined with substantial data gaps,
have constrained efforts to prioritise disorders in domestic dogs
[9]. Application of health data collected via a single national
surveillance system has been proposed for effective disorder
prioritisation, with the critical first step being the generation of
reliable disorder prevalence values [12].
Systematised collection, mergence and analysis of electronic
patient record (EPR) data from primary-care veterinary practices
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has been proposed for generation of reliable prevalence data
relating to the overall dog population [12,20]. Contemporaneous
recording of clinical information by veterinary health professionals
during episodes of care for every patient treated minimises
selection and recall biases in primary-care practice EPR data [20].
By contrast, referral caseloads may show selection bias towards
more complicated disorders [25], questionnaire surveys may incur
selection, recall and misclassification biases [26], and pet insurance
data are limited by selection bias emerging from age restrictions,
financial excesses and owner attributes [27].
This study aimed to use a database of merged primary-care
practice EPRs to estimate the prevalence of the most frequently
recorded disorders and syndromes in dogs attending primary-care
veterinary practices in England. The study further aimed to
evaluate associations between the occurrence of common disorders
with purebred/crossbred status and with popular breeds. It was
hypothesised that purebred dogs have a higher prevalence of
common disorders compared with crossbred dogs.
Materials and Methods
Ethics statement: Ethics approval was granted by the RVC
Ethics and Welfare Committee (reference number 2010 1076).
The VetCompass Animal Surveillance project collates de-
identified EPR data from primary-care veterinary practices in the
UK for epidemiological research [28]. The current study included
data collected from all clinics within the Medivet Veterinary
Group, a large network of integrated veterinary practices covering
central and south-eastern England [29]. Practitioners recorded
summary diagnosis terms from an embedded standard nomencla-
ture, the VeNom codes [30], at episodes of clinical care. EPR data
were extracted from practice management systems (PMSs) using
integrated clinical queries [31] and uploaded to a secure structured
query language (SQL) database. Information collected included
patient demographic (animal identification number, species,
breed, date of birth, sex, neuter status, insurance status, microchip
number and weight) and clinical information (free-form text
clinical notes, VeNom summary diagnosis terms and treatment,
with relevant dates) data fields.
The study sampling frame included all dogs that had at least one
EPR (clinical note, weight recording or treatment dispensed)
recorded within the VetCompass Animal Surveillance database
from September 1, 2009 to March 31, 2013. Sample size
calculations estimated that, from a study population of 140,000
dogs, a sample of 3,648 animals was required to represent a
disorder with 2.5% expected frequency with a precision of 0.5% at
a 95% confidence level [32].
A random sample of dogs was selected from the overall
sampling frame using an online random number generator (www.
random.org). Clinical notes and VeNom summary diagnosis terms
recorded during the study period were reviewed in detail, and the
most definitive diagnostic term recorded for each disorder
diagnosed within individual dogs was manually coded using the
most appropriate VeNom term. Elective (e.g. neutering) or
prophylactic (e.g. vaccination) clinical events were not included.
Multiple counting of disorder events for ongoing cases was avoided
by including recurring diagnoses of ongoing conditions only once
(e.g. repeated events of otitis externa) and by including only the
final diagnosis term recorded in cases with diagnosis revision over
time (e.g. following clinical work-up or trial therapy), based on the
assumption that diagnostic accuracy increased over time [33]. The
parent term was used for disorders that encompassed multiple
child terms [34] (e.g. a parent term road traffic accident (RTA) may
have multiple child terms such as laceration, fracture and hypovolaemic
shock). Disorder events that were aetiologically independent despite
sharing the same disorder term name (e.g. novel traumatic events)
were included separately. No distinction was made between pre-
existing and incident disorder presentations. Disorders described
within the clinical notes using presenting sign terms (e.g. ‘vomiting
and diarrhoea’), but without a formal clinical diagnostic term
being recorded, were included using the first sign listed (e.g.
vomiting). Dental disorders were included only if surgical or
medical intervention were recommended.
Recognisable single breeds [35] were grouped as ‘purebred’
while all other dogs were grouped as ‘crossbred’. Purebreds were
further categorised by Kennel Club (KC) breed-recognition
(recognised/not recognised) and KC breed group (gundog, hound,
pastoral, terrier, toy, utility, working) [36]. Neuter status was
defined by the final EPR neuter value and was combined with sex
to create four categories: female entire, female neutered, male
entire and male neutered. Insurance and microchip values
characterized the existence of a positive status at any time during
the study period. The maximum bodyweight (kg) recorded for
dogs aged over one year was categorised into seven groups (,10.0,
10.0–19.9, 20.0–29.9, 30.0–39.9, 40.0–49.9, $50.0, and ‘no
recorded weight’). The age (years) at the final EPR was categorised
into five groups (,1.0, 1.0–2.9, 3.0–5.9, 6.0–9.9, $10.0). Time
contributed to the study for each dog was calculated as the period
from the date of the earliest EPR to the date of the latest EPR. The
date and manner (euthanasia or non-assisted) [37] of deaths
recorded during the study were identified.
VeNom diagnostic terms for all recorded disorders were
extracted and mapped to three systems of terms for analysis:
diagnosis-level precision, mid-level precision and syndromic
classification. Diagnosis-level terms were one-to-one descriptors
of the original extracted terms at the maximal diagnostic precision
recorded within the clinical notes (e.g. inflammatory bowel disease
would remain as inflammatory bowel disease). Mid-level precision
terms were one-to-one descriptors of original diagnosis terms
defined at a general level of diagnostic precision (e.g. inflammatory
bowel disease would map to enteropathy). Syndromic classification
used three taxonomic groupings: body location, organ system and
pathophysiologic process. The number of syndromic terms that
could be mapped from each original diagnostic term was not
limited.
Study data were exported from the VetCompass database to a
spreadsheet (Microsoft Office Excel 2007, Microsoft Corp.) for
checking and cleaning before further export to Stata Version 11.2
(Stata Corporation) for statistical analyses. Demographic variables
were described statistically for the overall study population and the
sample group. Prevalence values with 95% confidence intervals
(CI) were tabulated for the twenty most prevalent diagnosis-level
and mid-level disorders and for all syndromic terms, and were
reported across all sampled dogs, purebreds only and crossbreds
only. Prevalence values for purebred and crossbred dogs were
compared statistically using the chi-squared test with Holm-
adjusted P-values to account for multiple testing effects [38].
Statistical significance was set at the 5% level. The CI estimates
were derived from standard errors based on approximation to the
normal distribution for disorders with ten or more events recorded
[39], but the Wilson approximation method was used for disorders
with fewer than ten events recorded [40]. Prevalence (95% CI)
values for the twenty most prevalent diagnosis-level and mid-level
disorders and for all syndromic terms were similarly derived,
reported and compared for popular breeds and crossbreds
(popular breeds had $100 dogs in the sample group).
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Results
The overall population comprised 148,741 dogs attending 93
clinics across central and south-eastern England. Demographic
examination of dogs with information available indicated that
117,179 (78.9%) were purebred, 71,002 (48.0%) were female,
61,120 (41.1%) were neutered, 43,435 (29.2%) were insured and
41,071 (27.6%) were microchipped. The median weight was
18.2 kg (interquartile range (IQR): 9.4–29.0, range: 0.68–105.0)
and the median age was 4.5 years (IQR: 1.6–8.7, range: 0.0–27.4)
(Table 1).
The study sample comprised 3,884 dogs attending 89 clinics. Of
dogs with information available, 3,079 (79.4%) were purebred,
1,817 (47.0%) were female, 1,735 (44.7%) were neutered, 1,226
(31.6%) were insured and 1,151 (29.6%) were microchipped. The
median weight was 17.3 kg (IQR: 9.1–28.4, range: 1.3–100.6) and
the median age was 4.8 years (IQR: 1.8–9.1, range: 0.0–21.24).
The most popular seven breeds accounted for 1,431 (36.8%) of the
study sample dogs (Table 1). Of the sampled dogs, 378 (9.7%) died
during the study period, with a median (IQR, range) age at death
of 12.3 years (9.2–14.4, 0.0–21.0) and 336 (88.9%) deaths
involving euthanasia. Overall, 2,945 (75.8%) dogs had at least
one disorder diagnosed, with the remainder having no disorders
diagnosed during the study period. The median (IQR, range)
number of disorders diagnosed per dog was 1.0 (1.0–3.0, 0.0–
21.0). The median (IQR, range) time contributed to the study per
dog was 0.7 years (0.0–3.5, 0.0–1.9). The sample and study
populations were similar across all measures assessed.
Among the sampled dogs, 8,025 unique disorder events were
recorded encompassing 430 distinct diagnosis-level disorder terms.
The most prevalent diagnosis-level disorders recorded were otitis
externa (number of events: 396, prevalence: 10.2%, 95% CI: 9.1–
11.3), periodontal disease (361, 9.3%, 95% CI: 8.3–10.3), anal sac
impaction (277, 7.1%, 95% CI: 6.1–8.1) and overgrown nails (276,
7.1%, 95% CI: 6.1–8.2). Purebred dogs had a significantly higher
prevalence compared with crossbreds for three of the twenty most-
prevalent diagnosis-level disorders: otitis externa (P = 0.001),
obesity (P = 0.006) and skin mass lesion (P = 0.033) (Table 2).
The prevalence of five of the twenty most-prevalent diagnosis-level
disorders differed statistically significantly between popular breeds:
periodontal disease (P = 0.002), overgrown nails (P = 0.004),
degenerative joint disease (P = 0.005), obesity (P = 0.001) and
lipoma (P = 0.003) (Table 3).
Within 54 mid-level diagnosis terms, the most prevalent
disorders were enteropathic (n = 692, prevalence: 17.8%, 95%
CI: 16.0–19.6), dermatological (602, 15.5%, 95% CI: 13.9–17.1),
musculoskeletal (457, 11.8%, 95% CI: 10.6–12.9) and aural (426,
11.0%, 95% CI: 9.8–12.2). Purebred dogs showed a significantly
higher prevalence than crossbreds for four of the twenty most-
prevalent mid-level disorders: dermatological (P = 0.004), aural
(P = 0.001), ophthalmological (P = 0.032) and obesity (P = 0.009)
(Table 4). Statistically significant differences in prevalence values
were shown between the most popular breeds in eight of the
twenty most-frequent mid-level disorders: musculoskeletal
(P = 0.002), claw/nail (P = 0.008), dental (P = 0.007), neoplastic
(P = 0.001), anal sac (P = 0.006), obesity (P = 0.004), cardiac
(P = 0.005) and brain (P = 0.003) (Table 5).
Syndromic classification analysis indicated that the most
prevalent body locations affected in dogs were the head-and-neck
(n = 1,273, prevalence = 32.8%, 95% CI: 30.7–34.9), abdomen
(993, 25.6%, 95% CI: 23.6–27.5) and limb (679, 17.5%, 95% C:
15.9–19.1). Purebreds had significantly higher prevalence values
compared with crossbreds for two of the eight body locations:
head-and-neck (P = 0.003) and tail (P = 0.038) disorders. The most
prevalent organ systems affected were the integument (1,408,
36.3%, 95% CI: 33.9–38.6), digestive (1,144, 29.5%, 95% CI:
27.5–31.5) and musculoskeletal (573, 14.8%, 95% CI: 13.8–16.0)
(Table 6). Purebreds had significantly higher prevalence values
than crossbreds for two of fifteen organ systems, namely
integument (P = 0.001) and auditory (P = 0.002) (Table 6). The
most prevalent pathophysiologic processes recorded were inflam-
mation (1,246, 32.1%, 95% CI: 29.8–34.3), mass/swelling (625,
16.1%, 95% CI: 14.6–17.6) and traumatic (557, 14.3%, 95% CI:
12.8–15.9). Purebreds had significantly higher prevalence values
than crossbreds for two of twenty-one pathophysiological process-
es: inflammatory (P = 0.006) and nutritional (P = 0.0014) disorders
(Table 7). Statistically significant differences in prevalence values
between the most popular breeds were shown for 5/8 body
location terms, 5/15 organ system terms and 5/21 pathophysio-
logic processes (Tables 8, 9 &10).
Discussion
This study reported the most prevalent disorders recorded in
dogs attending primary-care veterinary practices in England as
otitis externa, periodontal disease and anal sac impaction, while
the most prevalent disorder groups were enteropathic, dermato-
logical and musculoskeletal. The head-and-neck was the most
prevalent body location affected, the integument was the most
prevalent organ system affected, and inflammation was the most
prevalent pathophysiologic process. Some evidence was shown to
support higher disorder prevalence in purebred dogs compared
with crossbred dogs and for important differences in disorder
prevalence between breeds.
The current study was designed to fill a critical data gap relating
to disorder prevalence information that has been identified as a
constraint to improving dog welfare by effective reform of
purebred dog-breeding [20,21,22]. Unacceptably high occurrence
of inherited disorders in purebred dogs has been discussed since
over half a century ago [41,42,43,44], leading to implementation
of disease control measures such as defined health schemes
[45,46,47,48] and revised KC recommendations and rules for
registration and showing [44,49]. However, the current state and
predicted trajectory of purebred dog health remain contentious
despite these and other ongoing health measures, suggesting that
these earlier breeding reforms that were developed without access
to prioritisation information on the overall disorder burden may at
best have been sub-optimal, and potentially even counter-
productive [50].
Primary-care veterinary clinical data have been proposed as a
superior data resource for clinical research in dogs [12,20].
Although useful, alternative data sources including referral
practice data [51,52,53], pet insurance databases [27], official
health schemes [54,55,56] and large scale questionnaire surveys
[26,57,58,59] are reported to suffer many limitations for the
generation of prevalence values that can be generalised to the
wider dog population. Analyses based on primary-care veterinary
EPR data benefit from open-ended data collection allowing
generation of stronger evidence from cohort compared with cross-
sectional study designs [60,61,62]. Selection bias is reduced by
merging data collected from a miscellany of practices [63] and
recall and misclassification biases are reduced by collection of
clinical notes recorded contemporaneously by veterinary clinicians
during episodes of care [64]. Veterinary primary-care denomina-
tor populations are well-characterised demographically within
PMSs and include all practice-attending animals, whether
presenting healthy or sick, linked with comprehensive clinical
documentation that facilitates internal validation [27]. Registra-
Disorder Prevalence in Dogs
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tion databases from primary-care practices are more representa-
tive of the national dog population than other databases available
for research purposes; 77% of UK dogs are registered with a
veterinary practice compared with just 42% of UK dogs that are
insured and 31% of UK dogs that are registered with the KC [2].
Previous large-scale studies using primary-care practice clinical
data have been variably successful and have encountered problems
with sustainability. A cross-sectional study of paper-based clinical
records for 7,146 dogs from eight UK practices described
demographic and morbidity results but concluded that direct
electronic extraction of clinical data and implementation of
Table 1. Demographic information for sampled (n = 3,884) and overall study population (n = 148,741) dogs attending primary
veterinary practices in England.
Variable Category Sample: No. (%) Population: No. (%)
Sex/neuter Female entire 981 (25.4) 40,514 (27.4)
Female neutered 836 (21.6) 30,488 (20.6)
Male entire 1,152 (29.8) 46,459 (31.4)
Male neutered 899 (23.2) 30,635 (20.7)
Microchip Not microchipped 2,733 (70.4) 107,670 (72.4)
Microchipped 1,151 (29.6) 41,071 (27.6)
Purebred status Crossbred 797 (20.6) 31,354 (21.1)
Purebred 3,079 (79.4) 117,179 (78.9)
Popular breeds Crossbreed 797 (20.5) 31,354 (21.1)
Labrador Retriever 339 (8.7) 13,328 (9.0)
Staffordshire Bull Terrier 334 (8.6) 12,212 (8.2)
Jack Russell Terrier 262 (6.8) 10,006 (6.7)
Cocker Spaniel 133 (3.4) 5,579 (3.8)
German Shepherd Dog 132 (3.4) 5,314 (3.6)
Yorkshire Terrier 127 (3.3) 4,880 (3.3)
Border Collie 104 (2.7) 3,997 (2.7)
Other named breeds 1,656 (42.6) 62,071 (41.7)
KCa- breedb Not KC-recognised 306 (9.9) 11,717 (10.0)
KC-recognised 2,773 (90.1) 105,462 (90.0)
KCa groupc Gundog 737 (26.6) 28,832 (27.3)
Hound 178 (6.4) 6,505 (6.2)
Pastoral 284 (10.2) 11,530 (10.9)
Terrier 561 (20.2) 21,481 (20.4)
Toy 474 (17.1) 17,215 (16.3)
Utility 330 (11.9) 11,573 (11.0)
Working 209 (7.5) 8,326 (7.9)
Weight (kg) No recorded weight 1,260 (32.4) 52,308 (35.2)
,10.0 769 (19.8) 26,786 (18.0)
10.0–19.9 695 (17.9) 25,278 (17.0)
20.0–20.99 579 (14.9) 21,869 (14.7)
30.0–30.9 390 (10.0) 15,255 (10.3)
40.0–40.9 130 (3.4) 5,118 (3.4)
$50.0 61 (1.6) 2,127 (1.4)
Age (years) ,1.0 588 (15.2) 24,915 (16.8)
1.0–2.9 791 (20.4) 30,747 (20.7)
3.0–5.9 877 (22.6) 33,500 (22.5)
6.0–9.9 811 (20.9) 30,811 (20.7)
$10.0 814 (21.0) 28,664 (19.3)
Insurance Non-insured 2,658 (68.4) 105,306 (70.8)
Insured 1,226 (31.6) 43,435 (29.2)
aKC The Kennel Club.
bPercentage values based on purebred only.
cPercentage values based on KC-recognised dogs only.
doi:10.1371/journal.pone.0090501.t001
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standardised coding for breeds and disorders were required to
sustain long-term data collection [65]. In the US, the National
Companion Animal Study (NCAS) reported overall disorder
prevalence values using electronic records from 86,772 dogs
attending 63 private practices. However, prevalence estimation
was based only on the 36% of animals that had at least one coded
disorder term recorded and the full clinical notes were not
accessible for case-finding and internal validation exercises [66].
The National Companion Animal Surveillance System (NCASP)
was established using EPR data from over 500 Banfield Pet
Hospitals, but this system focused on the threat of emerging
infection, terrorist attack or natural disaster rather than disorder
prevalence [67] and has since been discontinued [68].
A standardised veterinary lexicon is critical for large-scale
epidemiological application of secondary clinical data
[52,65,69,70]. The VeNom codes [30] offers an open-access
veterinary nomenclature that has been developed collaboratively
between university and primary-care practice groups and facili-
tates both direct coding by attending clinicians at the point of
clinical care and also retrospective coding by researchers during
analysis. The VeNom coding ontology that is made available for
point-of-care coding defines multiple clinical fields including
species (45 terms), dog breeds (767), cat breeds (101), presenting
complaints (201), diagnostic tests (39), diagnoses (2,291) and
procedures (780).
The current study indicated that otitis externa (10.2%),
periodontal disease (9.3%), anal sac impaction (7.1%) and
overgrown nails (7.1%) were the most prevalent disorders recorded
in dogs attending veterinary practices in England. A US primary-
care study similarly identified dental calculus (20.5%), gingivitis
(19.5) and otitis externa (13.0%) as the most prevalent diagnoses in
dogs, but reported the prevalence of anal sac disease at only 2.5%,
and did not even include nail disorders within the common
disorders diagnosed [70]. An under-developed coding system,
inconsistent case definitions and selection bias from inclusion of
only the one-third of animals that had at least one coded diagnosis
term within the US study may explain these differing prevalence
trends and underscores the importance of standardised coding
systems for reliable comparisons between studies. The high
frequency of dental disease reported in the US study may have
resulted from inclusion of animals with any recorded dental
abnormality, regardless of severity. By contract, the current study
aimed to report the occurrence of dental disorders that currently
warranted treatment in the opinion of the attending clinician.
Study-inclusion of dental abnormalities of any nature provides
information on the summative effects from both current and
potential future clinically-significant dental disease whereas
including just current clinically-significant cases provides evidence
on the current welfare implications of dental disease. Both
approaches have merit and add to our understanding of the
substantial clinical relevance of dental disorders to the health and
welfare of dogs. A UK primary-care study using paper-based
clinical records identified the most prevalent disorders of dogs as
overgrown nails (2.7%), ascarid worm problems (2.3%), anal sac
impaction (2.1%), dental calculus (1.8%), fleas (1.8%), bacterial
otitis externa (1.7%), waxy otitis externa (1.2%), diarrhoea/
Table 2. Prevalence results for the most frequent disorders recorded in dogs, purebreds only and crossbreds only that attended
primary veterinary practices in England.
Overall Purebred Crossbred
Disorder No. Preva% 95% CIb Preva% 95% CIb Preva% 95% CIb P-value
Otitis externa 396 10.2 9.1–11.3 11.2 10.0–12.4 6.5 4.7–8.3 0.001
Periodontal disease 361 9.3 8.3–10.3 9.4 8.2–10.5 9.2 7.4–11.0 1.000
Anal sac impaction 277 7.1 6.1–8.1 7.1 6.0–8.1 7.5 5.7–9.4 1.000
Overgrown nails 276 7.1 6.1–8.2 6.9 5.8–8.0 8.0 6.1–9.9 1.000
Degenerative joint disease 256 6.6 5.7–7.5 6.4 5.3–7.4 7.5 5.7–9.4 1.000
Diarrhoea 249 6.4 5.5–7.4 6.8 5.6–8.0 4.9 3.4–6.4 0.255
Obesity 238 6.1 5.2–7.1 6.7 5.6–7.9 3.9 2.3–5.5 0.006
Traumatic injury 214 5.5 4.7–6.4 5.5 4.4–6.5 5.7 3.6–7.7 1.000
Conjunctivitis 192 4.9 4.1–5.8 5.2 4.2–6.2 4.1 2.8–5.5 1.000
Vomiting 159 4.1 3.3–4.9 4.0 3.1–4.9 4.5 3.0–6.0 1.000
Heart murmur 153 3.9 3.3–4.5 4.1 3.5–4.7 3.4 2.1–4.7 1.000
Lipoma 137 3.5 2.8–4.2 3.5 2.7–4.2 3.8 2.7–4.9 1.000
Dermatitis 134 3.5 2.8–4.1 3.5 2.8–4.3 3.1 1.9–4.4 1.000
Skin hypersensitivity 113 2.9 2.3–3.5 3.2 2.5–3.9 1.8 0.9–2.6 0.116
Skin mass 110 2.8 2.3–3.4 3.2 2.6–3.8 1.5 0.6–2.4 0.033
Claw injury 103 2.7 2.1–3.2 2.6 2.0–3.2 2.6 1.5–3.8 1.000
Behavioural 99 2.6 2.1–3.0 2.6 2.1–3.1 2.4 1.4–3.4 1.000
Gastroenteritis 99 2.6 2.0–3.1 2.4 1.9–2.9 3.1 2.0–4.3 1.000
Dog bite injury 97 2.5 1.9–3.1 2.4 1.7–3.1 2.9 1.8–4.0 1.000
Laceration 92 2.4 1.8–2.9 2.5 1.8–3.1 2.0 1.1–2.9 0.446
P-values (Holm-adjusted) represent comparison between purebreds and crossbreds.
aPrev prevalence.
b95% CI 95% confidence interval.
doi:10.1371/journal.pone.0090501.t002
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vomiting (1.0%) and Otodectes otitis externa (0.9%) [65]. Although
the predominance of aural, nail, anal sac and dental disorders
identified was consistent with the current study, the older study
reported prevalence per consultation values, leading to apparently lower
prevalence values than the current study that reported period
prevalence per dog. The substantially lower prevalence of parasitic
disorders reported in the current study may also reflect increasing
adoption and effectiveness of prophylactic parasiticides in the
intervening fifteen years since the previous study [71,72].
Although diagnosis-level disorder terms are useful to describe
disorders at their precision of clinical diagnosis, sole reliance on
these terms for research may mask important underlying disorder
concepts because of fragmentation into multiple terms along
diagnostic pathways. The current study grouped clinically-related
diagnosis-level terms (430 unique terms) into appropriate, com-
posite mid-level disorder terms (54 unique terms) for further
analysis. Selection of cut-off points for amalgamation along
diagnostic precision pathways aimed to optimise interpretability
whilst still retaining adequate precision [73]. The predominant
mid-level disorders (enteropathic, dermatological, musculoskeletal
and aural) differed from the predominant diagnosis-level disorders
(otitis externa, periodontal disease, anal sac impaction, overgrown
nails), suggesting that such hierarchical analysis can offer useful
insights that may otherwise be missed.
Syndromic surveillance is based on clinical features that are
discernible even from early presentation and are not dependent on
complete or even correct diagnosis for elucidation of diagnostic
patterns [74]. Although veterinary clinical diagnostic accuracy
may have improved over recent years, diagnostic discrepancies
have been identified in 15% of cases undergoing necropsy [75].
Syndromic surveillance has been applied within human bioterror-
ism surveillance [76] and for analysis of canine insurance data
[77,78]. The three syndromic classification systems used in the
current study (body location, organ system and pathophysiology)
were selected for their potential welfare importance via breed
conformation and genetic effects [15]. The syndromic coding
system used in the current study was adapted from VeNom codes
and other published veterinary lexicons in line with the disorder
types recorded within the study [25,79]. Progression towards a
standardised syndromic terminology would facilitate future inter-
study comparisons and meta-analyses [80].
The results from syndromic analyses in the current study
identified the most prevalent body locations affected by disorders
in dogs as the head-and-neck (32.8%), abdomen (25.6%) and limb
(17.5%). Morphologic diversity between breeds resulting from
artificial selection towards the extremes of breed standard
morphometrics [81] has been associated with conformational
predisposition for disorders [15,20]. The predominance of
disorders identified affecting the head-and-neck reaffirm the
importance of this body area to dog health [82].
The most affected organ systems identified by the current study
were the integument (36.3%), digestive (29.5%) and musculoskel-
etal (14.8%). Swedish insurance data analysis similarly identified
the most prevalently affected organs systems as the integument
(3.2%), gastrointestinal (2.7%) and genital (2.5%) [83]. A
consistently high prevalence reported by these studies for disorders
Table 4. Prevalence results for the most frequent mid-level disorders recorded in dogs, purebreds only and crossbreds only that
attended primary veterinary practices in England.
Overall Purebred Crossbred
Mid-level disorder No. Preva% 95% CIb Preva% 95% CIb Preva% 95% CIb P-value
Enteropathic 692 17.8 16.0–19.6 17.7 15.8–19.7 18.3 15.4–21.2 1.000
Dermatological 602 15.5 13.9–17.1 16.5 14.6–18.4 11.9 10.0–13.9 0.004
Musculoskeletal 457 11.8 10.6–12.9 11.2 9.8–12.6 14.1 11.8–16.3 0.130
Aural 426 11.0 9.8–12.2 12.0 10.7–13.3 7.2 5.3–9.0 0.001
Ophthalmological 406 10.5 9.1–11.8 11.1 9.7–12.6 7.9 6.1–9.7 0.032
Claw/nail 400 10.3 9.1–11.5 10.1 8.8–11.5 10.9 9.0–12.9 1.000
Dental 386 9.9 8.8–11.1 10.0 8.8–11.2 9.8 7.9–11.7 1.000
Neoplastic 367 9.5 8.2–10.7 9.6 8.2–10.9 9.2 7.2–11.1 1.000
Traumatic injury (not incl. bites) 351 9.0 8.0–10.1 9.1 7.8–10.3 8.9 6.6–11.2 1.000
Anal sac 337 8.7 7.5–9.8 8.6 7.3–9.9 9.0 7.1–11.0 1.000
Obesity 238 6.1 5.2–7.1 6.7 5.6–7.9 3.9 2.3–5.5 0.009
Mass lesion 235 6.1 5.2–6.9 6.4 5.3–7.4 4.9 3.4–6.4 0.726
Behavioural 233 6.0 5.3–6.85 5.8 4.9–6.7 6.9 5.1–8.7 1.000
Upper respiratory tract 223 5.7 4.9–6.5 5.6 4.6–6.6 6.4 4.6–8.2 1.000
Cardiac 219 5.6 4.8–6.5 5.9 5.0–6.7 4.9 3.1–6.7 1.000
Parasitic 172 4.4 3.8–5.1 4.2 3.5–5.0 5.3 3.7–6.8 1.000
Congenital 171 4.4 3.7–5.1 4.6 3.7–5.4 3.9 2.6–5.2 1.000
Bite injury 148 3.8 3.0–4.6 3.7 2.9–4.6 4.1 2.8–5.5 1.000
Urinary 126 3.2 2.7–3.8 3.4 2.7–4.1 2.8 1.6–3.9 1.000
Brain 122 3.1 2.5–3.7 3.2 2.6–3.8 3.1 1.9–4.4 1.000
P-values (Holm-adjusted) represent comparison between purebreds and crossbreds.
aPrev prevalence.
b95% CI 95% confidence interval.
doi:10.1371/journal.pone.0090501.t004
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affecting the integument and digestive systems suggests the
importance of clinical emphasis on maintaining the health of
these systems.
The current study identified inflammation (32.1%), mass/
swelling (16.1%) and trauma (14.3%) as the most prevalent
pathophysiologic processes affecting dogs. Similarly, a Swedish
insurance study identified inflammation (5.4%), symptomatic
(3.0%), trauma (2.7%) and neoplasia (2.1%) as the pathological
processes with the highest risk of morbidity [83]. Although an
essential adaptive response to injury, inflammation can behave
both physiologically (restoring homeostasis) and pathologically
(contributing to ongoing disease) [84]. The preponderance of
inflammatory disorders affecting dogs identified by the current
study suggests welfare gains from increased awareness by owners
of judicious use of anti-inflammatory medications and also the
value from ongoing research to better harness the healing aspects
of inflammation while limiting detrimental effects [85].
The current study hypothesised that purebred dogs have higher
prevalence of common disorders compared with crossbreds. This
hypothesis was founded on reports and studies that concluded
substantial detriment to purebred dog welfare from increasing
inherited health problems induced by inbreeding and selection for
extreme morphologies [15,16,20,21,22]. The study hypothesis was
tested by comparing prevalence values between purebreds and
crossbreds for each of the twenty most prevalent diagnosis-level
and mid-level disorders and for all syndromic presentations.
Purebreds showed significantly higher prevalence values for 13 of
the 84 (15.5%) disorders and syndromes evaluated. No instances
were identified in which prevalence values were significantly
higher in crossbred than in purebred dogs. These results provided
moderate evidence for higher disorder prevalence in purebreds
compared with crossbreds. However, additional analyses of
severity and duration data for these disorders would enable a
more comprehensive understanding of health disparities between
the groups [23].
Failure to show overwhelming evidence for disorder disparity
between purebred and crossbred dogs appears initially at odds
with the large body of literature apparently to the contrary
[20,21,22,86,87]. There are a number of possibilities for this
dissonance. Breed-specific conformational disorders within pure-
breds may be under-reported or under-recognised by both
veterinarians and owners because ‘normal for breed’ may have
become confused with ‘normal’ [88]. A study of dogs clinically
diagnosed with brachycephalic obstructive airway syndrome
(BOAS) identified that 58% of owners reported these dogs not
to have ‘breathing problems’ [82]. Purebred and crossbred dog
categories comprise heterogeneous mosaics of size, shape and
genetics. Merging this variation into single categories may have
masked important effects related to specific conformational,
physiological or behavioural features. Analyses of purebred or
crossbred subgroups based on breed, behaviour or body attributes
may better elucidate important health hazards, benefits and
associations.
Table 7. Prevalence of syndromic disorders related to pathophysiologic processes recorded in overall dogs, purebreds only and
crossbreds only that attended primary veterinary practices in England.
Overall Purebred Crossbred
Pathophysiologic process No. Preva% 95% CIb Preva% 95% CIb Preva% 95% CIb P–value
Inflammation 1,246 32.1 29.8–34.3 33.2 30.7–35.7 28.1 25.1–31.2 0.006
Mass/swelling 625 16.1 14.6–17.6 16.7 15.0–18.4 14.1 11.8–16.3 0.222
Traumatic 557 14.3 12.8–15.9 14.3 12.7–16.0 14.3 11.6–17.0 1.000
Degenerative 411 10.6 9.4–11.8 10.4 9.0–11.7 11.4 9.1–13.8 1.000
Infectious 388 10.0 9.0–11.0 10.3 9.1–11.4 9.0 6.9–11.2 1.000
Neoplastic 336 8.7 7.6–9.8 8.6 7.3–9.8 9.0 7.2–10.9 1.000
Congenital/developmental 332 8.6 7.4–9.7 8.9 7.6–10.2 7.3 5.6–9.2 0.870
Nutritional 320 8.2 7.1–9.4 8.9 7.5–10.2 5.9 4.3–7.5 0.014
Behavioural 262 6.8 5.9–7.6 6.5 5.5–7.4 7.9 6.0–9.8 1.000
Hereditary 232 6.0 5.1–6.9 6.2 5.1–7.3 5.3 3.5–7.0 1.000
Parasitic 221 5.7 5.0–6.4 5.5 4.6–6.3 6.7 5.0–8.4 1.000
Iatrogenic 150 3.9 3.3–4.5 3.7 3.1–4.4 4.4 2.9–5.9 1.000
Foreign body 109 2.8 2.3–3.3 2.8 2.3–3.4 2.8 1.6–3.9 1.000
Death 65 1.7 1.2–2.2 1.6 1.1–2.1 2.1 1.2–3.1 1.000
Intoxicative 49 1.3 1.0–1.7 1.3 1.0–1.8 1.1 0.6–2.1 1.000
Haemostatic 38 1.0 0.7–1.3 1.1 0.8–1.5 0.5 0.2–1.3 0.496
Immune–mediated 38 1.0 0.7–1.3 1.1 0.8–1.5 0.5 0.2–1.3 0.620
Allergic 35 0.9 0.7–1.3 0.9 0.6–1.3 0.9 0.4–1.8 1.000
Thermoregulatory 17 0.4 0.3–0.7 0.4 0.2–0.7 0.6 0.3–1.5 1.000
Metabolic 8 0.2 0.1–0.4 0.2 0.1–0.4 0.3 0.1–0.9 1.000
Effusion 1 0.0 0.0–0.2 0.0 0.0–0.2 0.0 0.0–0.5 1.000
P–values (Holm–adjusted) represent comparison between purebreds and crossbreds.
aPrev prevalence.
b95% CI 95% confidence interval.
doi:10.1371/journal.pone.0090501.t007
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Purebred dogs comprise 75-80% of the overall UK dog
population [3,28], suggesting that a high proportion of crossbreds
are likely to be first or second filial offspring from purebred
progenitors and could be reasonably expected to show conforma-
tional and polygenic disorder occurrence at the midpoint between
the values for their parent breeds, with any additional health
benefits in crossbreds resulting from hybrid vigour effects [89].
From this perspective, the less-than-overwhelming evidence
provided by the current study for substantially lower prevalence
values in crossbred compared with purebred dogs does not refute
claims in the literature of rising prevalence values for inherited
disorders within purebred dogs. Instead, this suggests that the
overall disorder burden within crossbred dogs may reflect the
overall disorder burden in purebreds at any point in time. For
optimal understanding, disorder prevalence in purebreds should
be quantified by analysing cohort health data to identify trends
over time.
The most prevalent disorders identified in dogs within the
current study were complex disorders that have multiple
interacting environmental and genetic casual factors [90]: otitis
externa [91], periodontal disease [92], anal sac disorders [93], nail
disorders [94,95], degenerative joint disease [96], diarrhoea
[97,98], obesity [99], traumatic injury [100], conjunctivitis
[101], vomiting [101,102] and heart murmur [103,104]. It may
be useful for canine health research to move away from viewing
individual disorders as necessarily either inherited or non-inherited
[105] and towards an acknowledgement of relevant roles for both
genetic and environmental components in the majority of canine
disorders [106,107,108]. This acceptance will improve decision-
making on effective disease-control and breeding programs [109].
Application of estimated breeding values (EBVs) developed from
summative health information derived from a range of sources,
including health schemes and veterinary primary-care data, could
contribute integrally to novel disorder-control programs
[14,110,111].
A large body of literature supports the existence of disorder
predispositions affecting most dog breeds [15,16,112]. Despite
inclusion of just seven breeds in the current analysis, breed
associations were identified for 33.3% (28/84) of the disorders and
syndromes evaluated (diagnosis-level disorders 20% (5/20), mid-
level disorders 40% (8/20) and syndromic terms 34% (15/44)).
The high-risk breeds differed considerably between the disorders
in the current study, suggesting that rational health control
measures should focus on highly-predisposed disorders within at-
risk breeds. Future breed-specific studies are recommended to
report more precise prevalence estimates and for a wider range of
breeds. Early studies could focus on the fourteen high-profile
breeds identified by the KC as having higher health risks, mainly
due to conformational problems [113].
There were some limitations to the current study. The practices
participating in the study formed a single veterinary group that
extended across central and south-east England and may not be
representative of the overall veterinary practice structure in
England. Case definitions and diagnosis recording relied heavily
on the clinical acumen and note-making of attending practitioners.
The researchers made no attempts to second-guess underlying
disorders in cases with presenting signs (e.g. vomiting) recorded in
lieu of formal diagnoses. Inclusion of umbrella terms such as road
traffic accident without additional inclusion of the individual specific
injuries sustained within the primary event may have reduced the
apparent prevalence of fractures and lacerations but avoided
multiple counting of disorder events along axes of diagnostic
precision. The analyses based on popular breeds were exploratory
in nature and should be validated within larger confirmatory
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studies [114,115]. Holm adjustments to P-values were used to
constrain the number of false-positive findings resulting from
interpretation of multiple comparisons [38,115,116]. The current
study reported prevalence values but effective welfare prioritisation
would additionally benefit from the generation of accurate data on
disorder severity and duration [117].
Conclusion
This study describes the most frequently recorded disorders in
dogs in England and provides a prevalence baseline against which
to measure progress in canine health. The most prevalent
disorders recorded in dogs attending primary-care veterinary
practices in England were otitis externa, periodontal disease and
anal sac impaction, and the most prevalent disorder groups were
enteropathic, dermatological and musculoskeletal. The head-and-
neck was the body location most frequently affected by the
disorders recorded, the integument was the most prevalent organ
system affected and inflammation was the most prevalent
pathophysiologic process. The study identified some evidence that
purebred dogs had higher disorder prevalence compared with
crossbred dogs. Substantial variation was shown across breeds in
their prevalence of common disorders. These results suggest that
breeding reforms should target commonly diagnosed complex
disorders that are amenable to genetic improvement on a breed-
by-breed basis for the greatest population impact. The prevalence
information provided by this study fills a crucial data gap. Future
studies of disorder severity and duration would augment the
current results and contribute to increasingly effective strategies to
improve dog welfare based on disorder prioritisation.
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